Author:
Frommer W.,Archer L.,Boon B.,Brunius G.,Collins C. H.,Crooy P.,Doblhoff-Dier O.,Donikian R.,Economidis J.,Frontali C.,Gaal T.,Hamp S.,Haymerle H.,Houwink E. H.,Küenzi M. T.,Krämer P.,Lelieveld H. L. M.,Logtenberg M. Th.,Lupker J.,Lund S.,Mahler J. L.,Mosgaard Ch.,Normand-Plessier F.,Rudan F.,Simon R.,Tuijnenburg Muijs G.,Vranch S. P.,Werner R. G.
Publisher
Springer Science and Business Media LLC
Subject
Applied Microbiology and Biotechnology,General Medicine,Biotechnology
Reference21 articles.
1. BMFT (1986) Richtlinien zum Schutz vor Gefahren durch in vitro neukombinierte Nukleinsäuren. 5. überarbeitete Fassung, Bundesanzeiger Verlagsgesellschaft mbH, Köln
2. CEC (1991) Ad hoc working party on biotechnology pharmacy. Note for Guidance for minimizing the risk of transmitting agents causing sporgiform encephalopathy via medicinal products. Commission of the European Communities
3. CEC (1987) Committee for proprietary Medicinal Products / Ad Hoc Working Party on Biotechnology / Pharmacy, Commission of the European Community. Guidelines on the production and quality control of medicinal products derived by recombinant DNA technology. Trends in Biotechnology 5, G1-G4
4. CEC (1988) Committee for Proprietary Medicinal Products / Ad Hoc Working Party on Biotechnology / Pharmacy, Commission of the European Community. Guidelines on the production and quality control of monoclonal antibodies of murine origin intended for use in man. Trends in Biotechnology 6, G5-G8
5. Directive 90/219/EEC. Council Directive of 23 April 1990 on the contained use of genetically modified microorganisms (90/219/EEC). Official Journal of the European Communities No. L117/1, May 8, 1990
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献